Intelligent Bio Solutions Income Statement

Financials in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
Operating Revenue	4.22	3.05	3.11	1.26	-
Revenue	4.22	3.05	3.11	1.26	-
Revenue Growth	38.09%	-1.90%	147.58%	-36.54%	-
Cost of Revenue	2.17	1.81	1.69	0.93	-
Gross Profit	2.05	1.25	1.43	0.33	-
Selling, General & Admin	10.5	8.88	9.26	8.03	4.92
Research & Development	3.37	2.4	1.67	0.51	3.85
Other Operating Expenses	-0.68	-0.82	-0.42	-0.74	-0.44
Operating Expenses	14.36	11.67	11.71	8.76	8.34
Operating Income	-12.31	-10.42	-10.28	-8.44	-8.34
Interest Expense	-0.01	-0.06	-0.17	-0.22	-0.01
Interest & Investment Income	0.11	0.1	0.08	0.01	0.01
Currency Exchange Gain (Loss)	0.04	-0	-0	-0.01	-0
Other Non Operating Income (Expenses)	-	-	0.18	2.15	-
EBT Excluding Unusual Items	-12.17	-10.38	-10.19	-6.51	-8.33
Impairment of Goodwill	-	-	-	-4.16	-
Asset Writedown	-0.3	-0.22	-	-	-
Pretax Income	-12.47	-10.6	-10.19	-10.66	-8.33
Earnings From Continuing Operations	-12.47	-10.6	-10.19	-10.66	-8.33
Minority Interest in Earnings	0.04	0.04	0.03	0.03	0.03
Net Income	-12.43	-10.57	-10.16	-10.63	-8.31
Net Income to Common	-12.43	-10.57	-10.16	-10.63	-8.31
Net Income Growth	-	-	-	-	-
Shares Outstanding (Basic)	1	1	0	-	-
Shares Outstanding (Diluted)	1	1	0	-	-
Shares Change	179.27%	231.10%	-	-	-
EPS (Basic)	-8.44	-20.04	-63.77	-	-
EPS (Diluted)	-8.44	-20.04	-63.80	-	-
EPS Growth	-	-	-	-	-

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
Free Cash Flow	-12.05	-9.91	-9.79	-7.88	-3.74
Free Cash Flow Per Share	-8.18	-18.79	-61.48	-	-
Gross Margin	48.63%	40.85%	45.81%	25.99%	-
Operating Margin	-292.03%	-341.50%	-330.46%	-671.24%	-
Profit Margin	-294.91%	-346.23%	-326.40%	-845.89%	-
Free Cash Flow Margin	-285.94%	-324.62%	-314.71%	-627.15%	-
EBITDA	-11.15	-9.45	-9.31	-7.62	-
EBITDA Margin	-264.42%	-	-299.15%	-	-
D&A For EBITDA	1.16	0.97	0.97	0.81	-
EBIT	-12.31	-10.42	-10.28	-8.44	-8.34
EBIT Margin	-292.03%	-	-	-	-
Advertising Expenses	-	1.55	0.73	-	-

SEC Filings: 10-K · 10-Q